| EIPCX | QRCRX | EIPCX / QRCRX | |
| Total Expense Ratio | 0.69 | 0.93 | 74% |
| Annual Report Gross Expense Ratio | 0.69 | 0.93 | 74% |
| Fund Existence | 15 years | 12 years | - |
| Gain YTD | 28.205 | 30.332 | 93% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 50000000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.36B | 1.97B | 171% |
| Annual Yield % from dividends | 10.46 | 10.44 | 100% |
| Returns for 1 year | 41.38 | 44.15 | 94% |
| Returns for 3 years | 63.27 | 63.88 | 99% |
| Returns for 5 years | 100.76 | 121.03 | 83% |
| Returns for 10 years | 198.88 | 240.72 | 83% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IPOCX | 20.62 | 0.06 | +0.29% |
| Nomura Systematic Emerging Markets Eq C | |||
| UUPSX | 71.70 | N/A | N/A |
| ProFunds UltraEmerging Markets Svc | |||
| SHSSX | 72.40 | N/A | N/A |
| BlackRock Health Sciences Opps Instl | |||
| VMFGX | 563.30 | N/A | N/A |
| Vanguard S&P Mid-Cap 400 Growth Idx I | |||
| APSRX | 18.00 | -0.07 | -0.39% |
| NYLIM Fiera SMID Growth Class A | |||